gzr-123 and Schizophrenia

gzr-123 has been researched along with Schizophrenia* in 1 studies

Other Studies

1 other study(ies) available for gzr-123 and Schizophrenia

Article	Year
Neuromodulatory mechanism underlying the effect of the atypical dipeptide neuroleptic dilept. Bulletin of experimental biology and medicine, 2003, Volume: 136, Issue:5 We studied the effects of a new dipeptide neuroleptic Dilept (N-caproyl-L-prolyl-L-tyrosine methyl ester) on activity of neurotransmitter systems in the brain. Dilept possessed antidopamine, glutamate modulatory, and cholinomimetic properties. These data indicate that Dilept is of potential efficacy in relieving positive and negative symptoms of schizophrenia. Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Brain; Ketamine; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Proline; Schizophrenia; Tyrosine	2003

Article

Year

Neuromodulatory mechanism underlying the effect of the atypical dipeptide neuroleptic dilept.

Bulletin of experimental biology and medicine, 2003, Volume: 136, Issue:5

We studied the effects of a new dipeptide neuroleptic Dilept (N-caproyl-L-prolyl-L-tyrosine methyl ester) on activity of neurotransmitter systems in the brain. Dilept possessed antidopamine, glutamate modulatory, and cholinomimetic properties. These data indicate that Dilept is of potential efficacy in relieving positive and negative symptoms of schizophrenia.

Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Behavior, Animal; Brain; Ketamine; Male; Mice; Mice, Inbred C57BL; Neurotransmitter Agents; Proline; Schizophrenia; Tyrosine

2003